Friday, November 22, 2024
11/22/2024
The MS Department of Mental Health, with the MS Public Health Institute, and Bartkowski & Associates Research Team, proposes MS SPF Rx, which will permit MS to target prescription drug misuse specific to prevention. MS has been beset by increasing overdose death rates with the proliferation of high-potency opioids. MS SPF Rx will raise awareness about the dangers of sharing medications and work with pharmaceutical and medical communities on the risks of overprescribing. MS SPF Rx will also raise community awareness and bring prescription drug abuse prevention activities and education to schools, communities, and the healthcare system. The project team will facilitate SAMHSA’s tracking of reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans as success indicators. MS SPF Rx is governed by one overall goal: to increase awareness of prescription drug misuse and related risk behaviors of overprescribing and sharing of prescribed medication. Objective 1.1 is to, by the end of year 1, enhance and document improvements to the existing SUD/OUD prevention infrastructure to include a focus on prescription drugs, with attention to both the prevention implementation and evaluation infrastructures in MS. Strategies associated with Obj.1.1 include entry into PDMP data-use agreements; the creation and use of a MS SPF Rx Strategic Planning Opioid Reduction Team (SPORT); and the development of a strategic opioid plan. Evaluation infrastructure enhancements will include tracking the impact of quality improvement plans. Objective 1.2 is to increase by 10% of baseline Mississippians’ awareness of prescription drug misuse risk and reduce by 10% of baseline risk behaviors associated with overprescribing and sharing prescribed medications by the end of year 1. Activities related to Obj.1.2 include the creation of a menu of appropriate evidence-based prescription drug misuse prevention programs from which SPORT coordinators can choose, with emphasis on CSAP strategy variations (e.g., prevention education, environmental strategies, drug disposal); sharing data at regular intervals to foster data-driven implementation at community level; and fostering prescriber and pharmacist regulatory awareness/compliance using prescriber report cards, etc. Objective 1.3 is as follows: to increase MS’s utilization of PDMP data to decrease by 10% of baseline prescription drug misuse through the creation of a PDMP Prescriber Report Card Timely Response (PRCTR) protocol by the end of year 1. Key strategies linked to Obj.1.3 entail the creation of a PRCTR protocol in the MS SPF Rx strategic plan that delineates how to enlist PDMP data to foster opioid misuse prevention through data-driven EBP community programming, resource allocation, coalition optimization, technical assistance provision, etc.; and tracking the effects of the PRCTR protocol and integration of protocol refinements for the duration of the project. The team is prepared to implement MS SPF Rx in concert with other SAMHSA grants or, as a standalone project that will significantly enhance prevention.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
